Unknown

Dataset Information

0

Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model.


ABSTRACT: GLP-1 is an intestinal hormone with widespread actions on metabolism. Therapies based on GLP-1 are highly effective because they increase glucose-dependent insulin secretion in people with type 2 diabetes, but many reports suggest that GLP-1 has additional beneficial or, in some cases, potentially dangerous actions on other tissues, including the heart, vasculature, exocrine pancreas, liver, and central nervous system. Identifying which tissues express the GLP-1 receptor (GLP1R) is critical for the development of GLP-1-based therapies. Our objective was to use a method independent of GLP1R antibodies to identify and characterize the targets of GLP-1 in mice. Using newly generated glp1r-Cre mice crossed with fluorescent reporter strains, we show that major sites of glp1r expression include pancreatic ?- and ?-cells, vascular smooth muscle, cardiac atrium, gastric antrum/pylorus, enteric neurones, and vagal and dorsal root ganglia. In the central nervous system, glp1r-fluorescent cells were abundant in the area postrema, arcuate nucleus, paraventricular nucleus, and ventromedial hypothalamus. Sporadic glp1r-fluorescent cells were found in pancreatic ducts. No glp1r-fluorescence was observed in ventricular cardiomyocytes. Enteric and vagal neurons positive for glp1r were activated by GLP-1 and may contribute to intestinal and central responses to locally released GLP-1, such as regulation of intestinal secretomotor activity and appetite.

SUBMITTER: Richards P 

PROVIDER: S-EPMC4092212 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model.

Richards Paul P   Parker Helen E HE   Adriaenssens Alice E AE   Hodgson Joshua M JM   Cork Simon C SC   Trapp Stefan S   Gribble Fiona M FM   Reimann Frank F  

Diabetes 20131202 4


GLP-1 is an intestinal hormone with widespread actions on metabolism. Therapies based on GLP-1 are highly effective because they increase glucose-dependent insulin secretion in people with type 2 diabetes, but many reports suggest that GLP-1 has additional beneficial or, in some cases, potentially dangerous actions on other tissues, including the heart, vasculature, exocrine pancreas, liver, and central nervous system. Identifying which tissues express the GLP-1 receptor (GLP1R) is critical for  ...[more]

Similar Datasets

| S-EPMC7235081 | biostudies-literature
| S-EPMC5063673 | biostudies-literature
| S-EPMC6353817 | biostudies-literature
| S-EPMC5335921 | biostudies-literature
| S-EPMC5056407 | biostudies-literature
| S-EPMC5835204 | biostudies-literature
| S-EPMC4041798 | biostudies-literature
| S-EPMC1151432 | biostudies-other
| S-EPMC4109209 | biostudies-literature
| S-EPMC6687107 | biostudies-literature